DSIP 5mg

DSIP 5mg, also known as Delta Sleep-Inducing Peptide or emideltide, is a synthetic nonapeptide intended for laboratory, analytical, and scientific research applications.

DSIP was originally characterized as a nine-amino-acid peptide with the sequence:

Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu
WAGGDASGE

Early experimental research identified and characterized this peptide using animal models, establishing the defined nine-residue sequence that continues to make DSIP an interesting compound for neuropeptide and peptide-chemistry research.

Research Applications

DSIP may be useful in controlled laboratory investigations involving:

• Neuropeptide characterization
• Peptide structure and sequence analysis
• Neurological signaling research
• Molecular interaction studies
• Peptide stability and degradation
• Structure–activity relationship studies
• Analytical method development
• Peptide conformational research
• Biochemical pathway investigation
• Comparative neuropeptide studies

Research has also examined the molecular conformation and membrane-related behavior of DSIP, providing additional areas for analytical and biochemical investigation.

Product Information

• Product: DSIP
• Full Name: Delta Sleep-Inducing Peptide
• Alternative Name: Emideltide
• Strength: 5mg
• Classification: Synthetic nonapeptide
• Peptide Length: 9 amino acids
• Sequence: WAGGDASGE
• Primary Research Area: Neuro Research
• Intended Setting: Laboratory, analytical, and scientific research
• Supplier: Peptides R US

Why Researchers Study DSIP

DSIP has a defined and compact nine-amino-acid structure, making it suitable for experimental work involving peptide identity, molecular conformation, stability, analytical characterization, and neuropeptide-related research.

The 5mg research format provides a clearly identified quantity for controlled laboratory protocols and comparative peptide investigations.

Research Use Only

DSIP 5mg from Peptides R US is intended exclusively for laboratory, analytical, and scientific research.

It is not intended for human or veterinary consumption or administration and is not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition.

No dosage, injection, intranasal use, sleep-treatment protocol, therapeutic use, or other human-use instructions are provided or implied.

FDA currently states that compounded products containing emideltide/DSIP may raise issues involving immunogenicity, peptide-related impurities, and API characterization, and that FDA lacks sufficient safety information to determine whether it would cause harm when administered to humans.